dry eye disease

Aldeyra’s dry eye drug in trouble with FDA

Aldeyra faces FDA rejection risk for dry eye drug due to review issues

Anika Sharma

Aldeyra Therapeutics confronts a daunting situation as regulatory concerns cast doubt on the future of its dry eye disease medication, ...